Reviva Pharmaceuticals Holdings, Inc.NASDAQ:RVPH
- LAST PRICE3.0200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.0000/ 1
- Ask / Lots3.2000/ 1
- Open / Previous Close3.0000 / 3.0200
- Day Range
- 52 Week Range
- Volume139,500
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RVPH |
|---|---|---|
| 09:32 ET | 1314 | 3 |
| 09:34 ET | 450 | 3.04 |
| 09:36 ET | 100 | 3.045 |
| 09:38 ET | 100 | 3.0475 |
| 09:39 ET | 100 | 3.05 |
| 09:50 ET | 350 | 3.0592 |
| 09:52 ET | 200 | 3.05 |
| 09:54 ET | 1100 | 3.08 |
| 09:56 ET | 701 | 3.0603 |
| 09:57 ET | 100 | 3.07 |
| 09:59 ET | 500 | 3.08 |
| 10:01 ET | 100 | 3.07 |
| 10:03 ET | 1278 | 3.06 |
| 10:06 ET | 300 | 3.06 |
| 10:10 ET | 400 | 3.0504 |
| 10:14 ET | 200 | 3.065 |
| 10:17 ET | 200 | 3.08 |
| 10:19 ET | 1900 | 3.06 |
| 10:21 ET | 1015 | 3.07 |
| 10:24 ET | 100 | 3.06 |
| 10:32 ET | 746 | 3.051 |
| 10:42 ET | 1200 | 3.04 |
| 11:00 ET | 1700 | 3.04 |
| 11:06 ET | 100 | 3.04 |
| 11:11 ET | 100 | 3.04 |
| 11:13 ET | 100 | 3.04 |
| 11:18 ET | 500 | 3.045 |
| 11:20 ET | 2150 | 3.04 |
| 11:24 ET | 595 | 3.035 |
| 11:26 ET | 100 | 3.0301 |
| 11:29 ET | 250 | 3.0301 |
| 11:33 ET | 100 | 3.035 |
| 11:38 ET | 1694 | 3.03 |
| 11:40 ET | 200 | 3.025 |
| 11:42 ET | 100 | 3.02 |
| 11:47 ET | 450 | 3.02 |
| 11:56 ET | 200 | 3.025 |
| 12:00 ET | 450 | 3.025 |
| 12:03 ET | 2000 | 3.0229 |
| 12:07 ET | 200 | 3.015 |
| 12:09 ET | 7807 | 3.0131 |
| 12:12 ET | 1532 | 3.01 |
| 12:14 ET | 104 | 3.02 |
| 12:20 ET | 100 | 3.02 |
| 12:21 ET | 500 | 3 |
| 12:23 ET | 500 | 3.0227 |
| 12:25 ET | 1600 | 3.02 |
| 12:45 ET | 272 | 3 |
| 12:52 ET | 350 | 3.01 |
| 12:54 ET | 100 | 3.01 |
| 12:56 ET | 100 | 3.01 |
| 12:57 ET | 100 | 3.015 |
| 12:59 ET | 350 | 3.02 |
| 01:01 ET | 985 | 3.0197 |
| 01:06 ET | 2371 | 3.02 |
| 01:08 ET | 1700 | 3.03 |
| 01:10 ET | 994 | 3.03 |
| 01:12 ET | 200 | 3.02 |
| 01:19 ET | 982 | 3.04 |
| 01:21 ET | 1000 | 3.0201 |
| 01:24 ET | 1095 | 3.02 |
| 01:30 ET | 700 | 3.01 |
| 01:37 ET | 250 | 3 |
| 01:39 ET | 150 | 3.01 |
| 01:44 ET | 100 | 3.01 |
| 01:48 ET | 500 | 3.0161 |
| 01:55 ET | 200 | 3.02 |
| 02:04 ET | 700 | 3.02 |
| 02:11 ET | 200 | 3.02 |
| 02:13 ET | 1100 | 3.02 |
| 02:18 ET | 200 | 3.03 |
| 02:22 ET | 7666 | 3 |
| 02:24 ET | 16686 | 2.9905 |
| 02:26 ET | 129 | 2.99 |
| 02:27 ET | 8933 | 2.95 |
| 02:40 ET | 200 | 2.975 |
| 02:42 ET | 1728 | 2.97 |
| 02:44 ET | 7847 | 2.975 |
| 02:45 ET | 550 | 2.978 |
| 02:49 ET | 500 | 2.97 |
| 02:54 ET | 593 | 2.96 |
| 02:58 ET | 150 | 2.9609 |
| 03:03 ET | 425 | 2.97 |
| 03:14 ET | 3200 | 3.015 |
| 03:18 ET | 224 | 3.016 |
| 03:20 ET | 200 | 3.04 |
| 03:21 ET | 150 | 3.01 |
| 03:23 ET | 100 | 3.03 |
| 03:27 ET | 200 | 3.03 |
| 03:41 ET | 8071 | 3.05 |
| 03:45 ET | 1945 | 3.05 |
| 03:50 ET | 400 | 3.03 |
| 03:54 ET | 100 | 3.03 |
| 03:56 ET | 420 | 3.035 |
| 03:57 ET | 200 | 3.05 |
| 03:59 ET | 6706 | 3.02 |
Apr 16, 2024
DJ Reviva Pharm Holdings Price Target Maintained With a $17.00/Share by Benchmark, from 10:10AM ET on Tuesday Apr 16, 2024 by Dow Jones
10:10AM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 15, 2024
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia, from 8:30AM ET on Monday Apr 15, 2024 by Dow Jones
8:30AM ET on Monday Apr 15, 2024 by Dow JonesReviva Reports Full Year 2023 Financial Results and Recent Business Highlights, from 8:05AM ET on Monday Apr 15, 2024 by Dow Jones
8:05AM ET on Monday Apr 15, 2024 by Dow JonesPress Release: Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights, from 8:05AM ET on Monday Apr 15, 2024 by Dow Jones
8:05AM ET on Monday Apr 15, 2024 by Dow Jones
Mar 28, 2024
Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting, from 8:00AM ET on Thursday Mar 28, 2024 by Dow Jones
8:00AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Reviva Pharmaceuticals Holdings, Inc. | 84.3M | -1.8x | --- |
Company Information
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).
Contact Information
- Headquarters
- 10080 N Wolfe Road, Suite Sw3-200CUPERTINO, CA, United States 95014
- Phone
- 408-501-8881
- Fax
- 408-904-6270
Executives
- Independent Chairman of the Board
- Parag Saxena
- President, Chief Executive Officer, Director
- Laxminarayan Bhat
- Chief Financial Officer
- Narayan Prabhu
- Independent Director
- Leslie Funtleyder
- Independent Director
- Richard Margolin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $84.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 27.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.06 |
EPS | $-1.66 |
Book Value | $0.20 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
